Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis

Omonike A. Olaleye, William Ramses Bishai, Jun Liu

Research output: Contribution to journalArticle

Abstract

The discovery of anti-tuberculosis agents that target new pathways is crucial for effective short-term TB therapy that will limit the development of resistance. The clinical significance of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis, latent TB and Human Immunodeficiency Virus co-infection in tuberculosis patients have made the development of new antimycobacterials more imperative. A better understanding of the major pathways that are involved in the pathogenesis, survival, and dormancy of Mtb will aid in the identification of new drug targets. Here, we review the N-terminal methionine excision (NME) pathway as a potential drug target during host infection with M. tuberculosis. The removal of the N-terminal methionine is a requirement for some proteins prior to post-translational modifications and processing. Therefore, an understanding of the physiological relevance of the two families of enzymes at the center of NME - peptide deformylases and methionine aminopeptidases - has the prospect of adding novel targets and antimycobacterials to the pipeline.

Original languageEnglish (US)
JournalTuberculosis
Volume89
Issue numberSUPPL.1
DOIs
StatePublished - Dec 2009

Fingerprint

Mycobacterium tuberculosis
Methionine
Enzymes
Tuberculosis
Pharmaceutical Preparations
Aminopeptidases
Virus Diseases
Post Translational Protein Processing
Coinfection
HIV
Peptides
Survival
Infection
Proteins
Therapeutics

Keywords

  • Methionine aminopeptidase (MetAP)
  • Mycobacterium tuberculosis (Mtb)
  • N-Terminal methionine excision (NME)
  • Peptide deformylase (PDF)
  • Tuberculosis (TB)

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis. / Olaleye, Omonike A.; Bishai, William Ramses; Liu, Jun.

In: Tuberculosis, Vol. 89, No. SUPPL.1, 12.2009.

Research output: Contribution to journalArticle

@article{070caf970fd94c3fbd8b7d1d362dd3d0,
title = "Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis",
abstract = "The discovery of anti-tuberculosis agents that target new pathways is crucial for effective short-term TB therapy that will limit the development of resistance. The clinical significance of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis, latent TB and Human Immunodeficiency Virus co-infection in tuberculosis patients have made the development of new antimycobacterials more imperative. A better understanding of the major pathways that are involved in the pathogenesis, survival, and dormancy of Mtb will aid in the identification of new drug targets. Here, we review the N-terminal methionine excision (NME) pathway as a potential drug target during host infection with M. tuberculosis. The removal of the N-terminal methionine is a requirement for some proteins prior to post-translational modifications and processing. Therefore, an understanding of the physiological relevance of the two families of enzymes at the center of NME - peptide deformylases and methionine aminopeptidases - has the prospect of adding novel targets and antimycobacterials to the pipeline.",
keywords = "Methionine aminopeptidase (MetAP), Mycobacterium tuberculosis (Mtb), N-Terminal methionine excision (NME), Peptide deformylase (PDF), Tuberculosis (TB)",
author = "Olaleye, {Omonike A.} and Bishai, {William Ramses} and Jun Liu",
year = "2009",
month = "12",
doi = "10.1016/S1472-9792(09)70013-7",
language = "English (US)",
volume = "89",
journal = "Tuberculosis",
issn = "1472-9792",
publisher = "Churchill Livingstone",
number = "SUPPL.1",

}

TY - JOUR

T1 - Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis

AU - Olaleye, Omonike A.

AU - Bishai, William Ramses

AU - Liu, Jun

PY - 2009/12

Y1 - 2009/12

N2 - The discovery of anti-tuberculosis agents that target new pathways is crucial for effective short-term TB therapy that will limit the development of resistance. The clinical significance of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis, latent TB and Human Immunodeficiency Virus co-infection in tuberculosis patients have made the development of new antimycobacterials more imperative. A better understanding of the major pathways that are involved in the pathogenesis, survival, and dormancy of Mtb will aid in the identification of new drug targets. Here, we review the N-terminal methionine excision (NME) pathway as a potential drug target during host infection with M. tuberculosis. The removal of the N-terminal methionine is a requirement for some proteins prior to post-translational modifications and processing. Therefore, an understanding of the physiological relevance of the two families of enzymes at the center of NME - peptide deformylases and methionine aminopeptidases - has the prospect of adding novel targets and antimycobacterials to the pipeline.

AB - The discovery of anti-tuberculosis agents that target new pathways is crucial for effective short-term TB therapy that will limit the development of resistance. The clinical significance of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis, latent TB and Human Immunodeficiency Virus co-infection in tuberculosis patients have made the development of new antimycobacterials more imperative. A better understanding of the major pathways that are involved in the pathogenesis, survival, and dormancy of Mtb will aid in the identification of new drug targets. Here, we review the N-terminal methionine excision (NME) pathway as a potential drug target during host infection with M. tuberculosis. The removal of the N-terminal methionine is a requirement for some proteins prior to post-translational modifications and processing. Therefore, an understanding of the physiological relevance of the two families of enzymes at the center of NME - peptide deformylases and methionine aminopeptidases - has the prospect of adding novel targets and antimycobacterials to the pipeline.

KW - Methionine aminopeptidase (MetAP)

KW - Mycobacterium tuberculosis (Mtb)

KW - N-Terminal methionine excision (NME)

KW - Peptide deformylase (PDF)

KW - Tuberculosis (TB)

UR - http://www.scopus.com/inward/record.url?scp=72049124267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72049124267&partnerID=8YFLogxK

U2 - 10.1016/S1472-9792(09)70013-7

DO - 10.1016/S1472-9792(09)70013-7

M3 - Article

C2 - 20006307

AN - SCOPUS:72049124267

VL - 89

JO - Tuberculosis

JF - Tuberculosis

SN - 1472-9792

IS - SUPPL.1

ER -